
Neal Akhave
Assistant Professor · University of Texas M D Anderson Cancer Center
Credentials: · · · · · ·
History
Research
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Cancer Discovery · 2023 · Co-first of 66 authors · 174 citations
Mechanisms of Resistance to KRASG12C-Targeted Therapy
Review · Cancer Discovery · 2021 · First of 3 authors · 124 citations
JAMA Oncology · 2024 · 35 citations

10 papers

6 papers

6 papers

5 papers

5 papers

5 papers

5 papers

5 papers
Clinical trials
- 2025–2032
Site PI · Recruiting · Phase 2, Phase 3
TuHURA Biosciences, Inc.




